Navigation Links
Providence Service Corporation Releases Second Quarter Results
Date:8/6/2008

on

Consolidated Statements of Cash Flows

(in thousands)

(UNAUDITED)

Six months ended

June 30,

2008 2007

Operating activities

Net income $7,142 $6,895

Adjustments to reconcile net income

to net cash provided by operating

activities:

Depreciation 2,313 614

Amortization 4,173 1,423

Amortization of deferred financing

costs 1,201 91

Deferred income taxes (484) (91)

Stock based compensation 1,163 1,017

Excess tax benefit upon exercise of

stock options (185) -

Other 22 100

Changes in operating assets and

liabilities, net of effects

of acquisitions:

Billed and unbilled accounts

receivable, net (1,289) (2,623)

Management fee receivable (792) (1,474)

Other receivable (1,346) (2,212)

Restricted cash 457 -

Reinsurance liability reserve 2,094 278

Prepaid expenses and other (5,300) (1,622)

Accounts payable and accrued

expenses 3,667 (1,033)

Accrued transpo
'/>"/>

SOURCE Providence Service Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
2. Providence Service Corporation Announces 35% Revenue Growth with Third Quarter Results; Increases Revenue Guidance for 2007
3. Providence Service Corporation Completes Private Placement of $70 Million of Convertible Senior Subordinated Notes
4. Providence Service Corporation Signs Definitive Agreement to Acquire LogistiCare, the Nations Leading Case Management Provider Coordinating Non-Emergency Transportation Services for the Medicaid Population
5. LogistiCare, a Subsidiary of Providence Service Corp., Opens Phoenix Call Center to Support Expanding Commercial Client Base
6. Providence Service Corporation to Present at the 2008 UBS Global Healthcare Services Conference on February 11
7. Providence Health & Services - Oregon Region Powers Consumer Portal With Kryptiq Connect IQ
8. Providence Service Corporation to Report Fourth Quarter 2007 Results on Wednesday, March 12th After the Market Closes
9. Providence Service Corporation and UnitedHealth Group Affiliate, OptumHealth Behavioral Solutions, Enter Into Strategic Relationship Agreement
10. Providence Service Corporation Announces Fourth Quarter 2007 Revenue and Earnings Above Forecast; Issues First Quarter 2008 Guidance
11. Providence Service Corporation Announces Intent to File a Common Stock Shelf Registration Statement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)... National Non-profit Launches Age-related Macu... at No Cost to Eligible Patients and Free Eye-Heal...isco, CA (Vocus) December 2, 2008 -- "Do You ...an eye disease known as Age-related Macular Degene..., , , , ,Picture this…. a large black hole...
(Date:12/2/2008)...wire-FirstCall/ -- Motorola, Inc. (NYSE: MOT ),...erbroadband system to enable,three hospitals mana...r,Generale de Sante to deliver voice, data and v...rovides an advanced IP broadband infrastructure to...xisting telephone line, eliminating,the need for ...
(Date:12/1/2008)... & Allergy Friendly, Toy Puppies to the Obama ...e-USNewswire/ -- Much has been made of President-E...But concerns about his daughter,s asthma and aller...ad from making a decision. So, in the meantime, t... is donating 2 "asthma & allergy friendly" toy...
(Date:12/1/2008)...s found that positron emission mammography (PEM), ...ected by either breast density or a woman,s hormon...s of standard mammography and MRI at detecting can... meeting of the Radiological Society of North Amer...er does not appear to be adversely affected by bre...
Breaking Medicine News(10 mins):Health News:This Holiday Season EyeCare America Asks Seniors, 'Do you see what I see?' 2Health News:This Holiday Season EyeCare America Asks Seniors, 'Do you see what I see?' 3Health News:Motorola Extends the Delivery of Personalized Media Experiences to Hospital Group Generale De Sante 2Health News:Motorola Extends the Delivery of Personalized Media Experiences to Hospital Group Generale De Sante 3Health News:Asthma and Allergy Foundation Helps New First-Dad Keep His First Promise 2Health News:New mammography technology effective in detecting breast cancer 2
...Biotechnologies, Inc., a wholly-owned subsidiary o... novel powder-based vaccine delivery technology m...uenza pandemic preparedness which were discussed b...ol of Influenza VI Conference" held in Toronto, Ca...
...r US vice president and presently a high profile e...rally, across the world Saturday next. He is behin... pop and rock music featuring various artists plan...7, 2007 to promote action to confront the global w...
...ithstanding, violent hate crimes on the rise again... Nearly four in 10 gay men and about one in eight ...een the target of violence or a property crime bec...ientation, according to a new study. "This is the...
...the abattoir, especially because it is afflicted w...m the mad cow disease that took a heavy toll of t...-year-old Freisian bull to the slaughterhouse is b...t" Hindus of Carmarthenshire, a tiny hamlet in Wal...
Other Medicine News:Health News:DelSite Working Toward Solving Delivery of Influenza Vaccine in Pandemic Situations 2Health News:DelSite Working Toward Solving Delivery of Influenza Vaccine in Pandemic Situations 3Health News:Live Earth Will Make the World More Aware of the Crisis Facing the Earth, Hopes Al Gore 2Health News:Live Earth Will Make the World More Aware of the Crisis Facing the Earth, Hopes Al Gore 3Health News:Hate Crimes Against Gays and Lesbians Rising in US 2Health News:Shambu With Bovine TB Being Prevented from Slaughter 2
(Date:12/1/2008)...n has announced that an oral,presentation of pre...nical,trial of TG101348 in myeloproliferative dis...ican Society of Hematology (ASH) Meeting. , , ... Title: A Phase I Study of TG10134... JAK2-Selective Inhibitor, in Patients with, ...
(Date:12/1/2008)... , , ROCHESTER, Minn., Dec. 1 /PRNewswire-...the use of the drug therapy etanercept ineffective...ation of the liver caused by excessive consumption...d in the December issue of Gastroenterology ( ht...LERT: Additional audio and video resources, includ...
(Date:12/1/2008)...-- Vical Incorporated (Nasdaq: VICL ) announced ...ent from Merck & Co., Inc. based on Merck,s pl... investigational plasmid DNA (pDNA) cancer vaccine...ne delivery technology and encodes human telomeras...ect of separate license agreement. , , "The...
(Date:11/27/2008)...phoblastic leukemia relapse cases arise from a cel..., MEMPHIS, Tenn., Nov. 27 /PRNewswire-USNewswire...spital have identified distinctive genetic changes...blastic leukemia (ALL) that cause relapse. The fin...ALL relapse in children and, ultimately, in adults...
Breaking Medicine Technology:Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3American Society for Microbiology honors Vickie S Baselski 4075 1American Society for Microbiology honors Vickie S Baselski 4075 2American Society for Microbiology honors Vickie S Baselski 4075 3American Society for Microbiology honors Vickie S Baselski 4075 4The TPAA Names Mark Oelschlager President 6584 1The TPAA Names Mark Oelschlager President 6584 2Booster vaccination may help with possible future avian influenza pandemic 24115 1Booster vaccination may help with possible future avian influenza pandemic 24115 2Booster vaccination may help with possible future avian influenza pandemic 24115 3VSP Vision Care Takes Tax Exempt Appeal to Supreme Court 24112 1VSP Vision Care Takes Tax Exempt Appeal to Supreme Court 24112 2VSP Vision Care Takes Tax Exempt Appeal to Supreme Court 24112 3
...igestive Disease Week -, CAMBRIDGE, Mass., May 21,... presentation of data from a Phase 2 study in whic...oved bowel function,in patients with constipation-...se data also showed linaclotide was well tolerated...de is a first-in-class,compound currently being de...
...ay 21, 2007 - Medical,professionals seeking to tre...uired gram-negative pneumonia may have a new weapo... candidate being,developed by Nektar Therapeutics ...al evaluating the use of,NKTR-061 (Inhaled Amikaci...hospital-acquired gram-negative pneumonia were,pre...
Other Medicine Technology:Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 2Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 3Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 4Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 2Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 3Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 4Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 5Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 6Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 7Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 8Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 9Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 10Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 11
The Anterior Isola System is intended for use in correcting scoliotic, lordotic or kyphotic spinal deformities by establishing an axially stiff fixation bridge parallel to the long axis of the spine.
...Bowman Perfusion Monitor measures focal tissue per.... This precision instrument activates the minimall... connected by an umbilical cord to collect the dat... a host PC via serial port for processing, storage...
The Laserflo BPM2 is designed to give accurate and continuous cerebral blood flow data in neurosurgical intensive care, trauma, and operating room settings. The system is safe and easy to use, and pr
Oxyflo is a highly featured laser doppler system for continuous monitoring of microvascular blood perfusion from multiple tissue sites. This latest generation system incorporates developments in Digi
Medicine Products: